![Stephen W. Kaldor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen W. Kaldor
Fondateur chez
Fount Therapeutics LLC
Profil
Stephen W.
Kaldor is the founder of Fount Therapeutics LLC, serving as Chief Executive Officer & Director since 2016.
Dr. Kaldor was the founder of Kinnate Biopharma, Inc., serving as Director from 2020 to 2021.
Dr. Kaldor was the founder of XinThera, Inc., serving as Chairman.
Current job includes Director at Resolute Therapeutics, Inc. since 2016.
Former jobs include President & Chief Executive Officer at Ambrx, Inc. from 2007 to 2010, President, Chief Executive Officer & Director at Quanticel Pharmaceuticals, Inc. from 2011 to 2015, Director at Amira Pharmaceuticals, Inc. from 2008 to 2011, Independent Director at Furiex Pharmaceuticals, Inc. from 2012 to 2014, Director at Bird Rock Bio Sub, Inc., Independent Director at Crinetics Pharmaceuticals, Inc. from 2015 to 2021, Principal at Eli Lilly & Co. from 1989 to 2001, President & Chief Scientific Officer at Syrrx, Inc. in 2005, Venture Partner at Versant Venture Management LLC, and President & Chief Scientific Officer at Takeda San Diego, Inc. from 2005 to 2007.
Education includes undergraduate degree from The Trustees of Columbia University in The City of New York and doctorate from Harvard University, conferred in 1989.
Postes actifs de Stephen W. Kaldor
| Sociétés | Poste | Début |
|---|---|---|
Fount Therapeutics LLC
 Fount Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates a drug discovery enterprise | Fondateur | 01/12/2016 |
Resolute Therapeutics, Inc.
 Resolute Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur/Membre du Conseil | 01/10/2016 |
Anciens postes connus de Stephen W. Kaldor
| Sociétés | Poste | Fin |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 22/06/2021 |
| KINNATE BIOPHARMA INC. | Directeur Général | - |
Quanticel Pharmaceuticals, Inc.
 Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the development of medicines for the treatment of cancer | Directeur Général | 01/10/2015 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Corporate Officer/Principal | 01/10/2015 |
| FURIEX PHARMACEUTICALS INC | Directeur/Membre du Conseil | 02/07/2014 |
Formation de Stephen W. Kaldor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Amira Pharmaceuticals, Inc.
 Amira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development collaboration company | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Takeda San Diego, Inc.
 Takeda San Diego, Inc. Medical DistributorsDistribution Services Discovers drugs for cancer treatment | Distribution Services |
Bird Rock Bio Sub, Inc.
 Bird Rock Bio Sub, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the development of medicines for the treatment of cancer | Health Technology |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Fount Therapeutics LLC
Fount Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates a drug discovery enterprise | Health Technology |
Resolute Therapeutics, Inc.
Resolute Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Produces novel oncology and immunology drugs | Health Technology |
